Emerging roles of T helper 17 and regulatory T cells in lung cancer progression and metastasis
Open Access
- 27 October 2016
- journal article
- review article
- Published by Springer Science and Business Media LLC in Molecular Cancer
- Vol. 15 (1), 1-15
- https://doi.org/10.1186/s12943-016-0551-1
Abstract
Lung cancer is a leading cause of cancer-related deaths worldwide. Lung cancer risk factors, including smoking and exposure to environmental carcinogens, have been linked to chronic inflammation. An integral feature of inflammation is the activation, expansion and infiltration of diverse immune cell types, including CD4+ T cells. Within this T cell subset are immunosuppressive regulatory T (Treg) cells and pro-inflammatory T helper 17 (Th17) cells that act in a fine balance to regulate appropriate adaptive immune responses. In the context of lung cancer, evidence suggests that Tregs promote metastasis and metastatic tumor foci development. Additionally, Th17 cells have been shown to be an integral component of the inflammatory milieu in the tumor microenvironment, and potentially involved in promoting distinct lung tumor phenotypes. Studies have shown that the composition of Tregs and Th17 cells are altered in the tumor microenvironment, and that these two CD4+ T cell subsets play active roles in promoting lung cancer progression and metastasis. We review current knowledge on the influence of Treg and Th17 cells on lung cancer tumorigenesis, progression, metastasis and prognosis. Furthermore, we discuss the potential biological and clinical implications of the balance among Treg/Th17 cells in the context of the lung tumor microenvironment and highlight the potential prognostic function and relationship to metastasis in lung cancer.Keywords
Funding Information
- Canadian Institutes of Health Research (MOP-123273, MOP-110949)
- Canadian Cancer Society (CCSRI#702535, CCSRI#702520)
- National Sanitarium Association
- Terry Fox Research Institute
This publication has 164 references indexed in Scilit:
- Systematic Review and Meta-Analysis on the Association between IL-1B Polymorphisms and Cancer RiskPLOS ONE, 2013
- Th17 Lymphocytes in Respiratory Syncytial Virus InfectionViruses, 2013
- Increase of regulatory T cells in metastatic stage and CTLA-4 over expression in lymphocytes of patients with non-small cell lung cancer (NSCLC)Lung Cancer, 2012
- Pharmacological antioxidant strategies as therapeutic interventions for COPDBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2012
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Functional Specialization of Interleukin-17 Family MembersImmunity, 2011
- Increased IL-17-producing cells correlate with poor survival and lymphangiogenesis in NSCLC patientsLung Cancer, 2010
- CC chemokine ligand 2 (CCL2) promotes prostate cancer tumorigenesis and metastasisCytokine & Growth Factor Reviews, 2010
- T Helper 17 Cells Promote Cytotoxic T Cell Activation in Tumor ImmunityImmunity, 2009
- FOXP3 and the regulation of Treg/Th17 differentiationMicrobes and Infection, 2009